Free Trial

10x Genomics (TXG) News Today

10x Genomics logo
$8.59 +0.42 (+5.14%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$8.66 +0.07 (+0.80%)
As of 05/27/2025 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Why is 10x Genomics Up Today?

10x Genomics, Inc. (NASDAQ:TXG) shares are trading lower today after company insiders sold stock and Weiss Ratings reiterated a negative outlook.

  • Short interest was reported at 0 shares, leaving a 0.0 days-to-cover ratio
  • CFO Adam Taich sold 4,044 shares at an average price of $8.30 (≈$33,565 total)
  • Insider Benjamin J. Hindson sold 7,485 shares at an average price of $8.30 (≈$62,126 total)
  • CEO Serge Saxonov sold 9,343 shares at an average price of $8.30 (≈$77,547 total)
  • Weiss Ratings reiterated a “Sell (E+)” rating on the stock

Investors may view clustered insider selling alongside a reaffirmed sell rating as bearish signals, contributing to downward pressure on TXG shares.

Posted 5h agoAI Generated. May Contain Errors.

TXG Latest News

10x Genomics (NASDAQ:TXG) Earns Sell (E+) Rating from Weiss Ratings
10x Genomics, Inc. stock logo
Squarepoint Ops LLC Sells 121,729 Shares of 10x Genomics, Inc. (NASDAQ:TXG)
Squarepoint Ops LLC lessened its position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 17.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 590,510 shares of the company's stock after selling 121,729 shares during
10x Genomics, Inc. stock logo
10x Genomics, Inc. (NASDAQ:TXG) Shares Purchased by Man Group plc
Man Group plc increased its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 77.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 126,666 shares of the company's stock after purchasing a
10x Genomics, Inc. stock logo
10x Genomics, Inc. (NASDAQ:TXG) Shares Sold by Bank of America Corp DE
Bank of America Corp DE lowered its position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 30.0% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 654,999 shares of the company's stock after selling 281,259 shares during the quart
10x Genomics, Inc. stock logo
Voloridge Investment Management LLC Boosts Holdings in 10x Genomics, Inc. (NASDAQ:TXG)
Voloridge Investment Management LLC lifted its stake in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 12.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,585,965 shares of the company's stock after purchas
10x Genomics, Inc. stock logo
Two Sigma Investments LP Has $18.95 Million Stock Position in 10x Genomics, Inc. (NASDAQ:TXG)
Two Sigma Investments LP increased its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 291.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,319,487 shares of the company's stock after acquiring an
10x Genomics, Inc. stock logo
10x Genomics (NASDAQ:TXG) Upgraded by Wall Street Zen to Buy Rating
Wall Street Zen raised 10x Genomics from a "hold" rating to a "buy" rating in a report on Thursday.
10x Genomics, Inc. stock logo
10x Genomics, Inc. (NASDAQ:TXG) Shares Acquired by Two Sigma Advisers LP
Two Sigma Advisers LP increased its position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 240.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,236,200 shares of the company's stock after buying an add
10x Genomics, Inc. stock logo
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $2.29 Million Stake in 10x Genomics, Inc. (NASDAQ:TXG)
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 37.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 159,165 shares of the company's
10x Genomics, Inc. stock logo
Quantinno Capital Management LP Has $2.15 Million Position in 10x Genomics, Inc. (NASDAQ:TXG)
Quantinno Capital Management LP trimmed its stake in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 36.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 149,833 shares of the company's stock after selling 85,193 shar
10x Genomics, Inc. stock logo
10x Genomics, Inc. (NASDAQ:TXG) Shares Sold by Northern Trust Corp
Northern Trust Corp trimmed its holdings in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 5.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 561,666 shares of the company's stock afte
10x Genomics, Inc. stock logo
Jacobs Levy Equity Management Inc. Buys Shares of 31,367 10x Genomics, Inc. (NASDAQ:TXG)
Jacobs Levy Equity Management Inc. bought a new stake in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 31,367 shares of the company's
10x Genomics, Inc. stock logo
Jefferies Financial Group Inc. Has $446,000 Stock Holdings in 10x Genomics, Inc. (NASDAQ:TXG)
Jefferies Financial Group Inc. trimmed its position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 90.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 31,048 shares of the company's stock after selling 284,0
10x Genomics, Inc. stock logo
Numerai GP LLC Has $2.27 Million Stake in 10x Genomics, Inc. (NASDAQ:TXG)
Numerai GP LLC raised its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 66.8% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 157,792 shares of the company's stock after purchasing an addition
10x Genomics, Inc. stock logo
Cresset Asset Management LLC Cuts Position in 10x Genomics, Inc. (NASDAQ:TXG)
Cresset Asset Management LLC lessened its holdings in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 69.6% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 41,619 shares of the company's stock after selling 95,302 shares during the qua
10x Genomics, Inc. stock logo
Meridiem Capital Partners LP Invests $4.92 Million in 10x Genomics, Inc. (NASDAQ:TXG)
Meridiem Capital Partners LP bought a new stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 342,870 shares of the company's stock, valued at approximately $4,924,0
10x Genomics, Inc. stock logo
D. E. Shaw & Co. Inc. Invests $17.50 Million in 10x Genomics, Inc. (NASDAQ:TXG)
D. E. Shaw & Co. Inc. purchased a new stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 1,218,598 shares of the company's stock, valued at approximately $17,
10x Genomics, Inc. stock logo
Balyasny Asset Management L.P. Buys 95,820 Shares of 10x Genomics, Inc. (NASDAQ:TXG)
Balyasny Asset Management L.P. increased its stake in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 216.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 140,075 shares of the company's stock after purcha
10x Genomics, Inc. stock logo
The Manufacturers Life Insurance Company Trims Stake in 10x Genomics, Inc. (NASDAQ:TXG)
The Manufacturers Life Insurance Company reduced its position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 32.6% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 88,820 shares of the company's stock after
10x Genomics, Inc. stock logo
The Goldman Sachs Group Lowers 10x Genomics (NASDAQ:TXG) Price Target to $6.50
The Goldman Sachs Group dropped their price target on 10x Genomics from $7.50 to $6.50 and set a "sell" rating on the stock in a research note on Monday.
10x Genomics, Inc. stock logo
10x Genomics (NASDAQ:TXG) Given New $15.00 Price Target at Canaccord Genuity Group
Canaccord Genuity Group dropped their price target on shares of 10x Genomics from $18.00 to $15.00 and set a "buy" rating on the stock in a research note on Monday.
10x Genomics, Inc. stock logo
189,221 Shares in 10x Genomics, Inc. (NASDAQ:TXG) Bought by Invenomic Capital Management LP
Invenomic Capital Management LP purchased a new position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 189,221 shares of the company's stock, v
10x Genomics, Inc. stock logo
BNP Paribas Financial Markets Purchases Shares of 632,531 10x Genomics, Inc. (NASDAQ:TXG)
BNP Paribas Financial Markets purchased a new stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 632,531 shares of the company's stock, valu
10x Genomics, Inc. stock logo
Jane Street Group LLC Purchases 117,449 Shares of 10x Genomics, Inc. (NASDAQ:TXG)
Jane Street Group LLC boosted its position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 48.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 360,257 shares of the company's stock after acquiring an addition
10x Genomics, Inc. stock logo
Cubist Systematic Strategies LLC Raises Position in 10x Genomics, Inc. (NASDAQ:TXG)
Cubist Systematic Strategies LLC increased its position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 49.4% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 334,632 shares of the company's st
10x Genomics, Inc. stock logo
30,005 Shares in 10x Genomics, Inc. (NASDAQ:TXG) Purchased by Raymond James Financial Inc.
Raymond James Financial Inc. acquired a new stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 30,005 shares of the company's stock, valued at approximately $431,000. Other large
10x Genomics, Inc. stock logo
10x Genomics (NASDAQ:TXG) Receives Sell (E+) Rating from Weiss Ratings
Weiss Ratings restated a "sell (e+)" rating on shares of 10x Genomics in a research report on Saturday.
10x Genomics, Inc. stock logo
AQR Capital Management LLC Decreases Position in 10x Genomics, Inc. (NASDAQ:TXG)
AQR Capital Management LLC decreased its position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 29.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 517,202 shares of the company's stock
10x Genomics, Inc. stock logo
Schonfeld Strategic Advisors LLC Raises Holdings in 10x Genomics, Inc. (NASDAQ:TXG)
Schonfeld Strategic Advisors LLC increased its position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 140.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 151,693 shares of the company's sto
10x Genomics, Inc. stock logo
Algert Global LLC Has $9.49 Million Holdings in 10x Genomics, Inc. (NASDAQ:TXG)
Algert Global LLC lifted its stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 78.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 660,620 shares of the company's stock after purcha
10x Genomics, Inc. stock logo
First Trust Advisors LP Buys 133,841 Shares of 10x Genomics, Inc. (NASDAQ:TXG)
First Trust Advisors LP raised its position in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 159.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 217,558 shares of the company's stock after ac
10x Genomics, Inc. stock logo
10x Genomics, Inc. (NASDAQ:TXG) Given Consensus Recommendation of "Hold" by Brokerages
Shares of 10x Genomics, Inc. (NASDAQ:TXG - Get Free Report) have been given a consensus rating of "Hold" by the sixteen brokerages that are covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and seven have given a
10x Genomics, Inc. stock logo
Tudor Investment Corp ET AL Sells 109,061 Shares of 10x Genomics, Inc. (NASDAQ:TXG)
Tudor Investment Corp ET AL cut its stake in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 35.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 200,011 shares of the company's stock after selling 109,061 shares durin
10x Genomics, Inc. stock logo
10x Genomics, Inc. (NASDAQ:TXG) Shares Sold by Marshall Wace LLP
Marshall Wace LLP trimmed its position in 10x Genomics, Inc. (NASDAQ:TXG - Free Report) by 90.0% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 46,861 shares of the company's stock after selling 420,262 shares during the period. Marsha
10x Genomics, Inc. stock logo
RA Capital Management L.P. Purchases Shares of 3,279,401 10x Genomics, Inc. (NASDAQ:TXG)
RA Capital Management L.P. bought a new stake in shares of 10x Genomics, Inc. (NASDAQ:TXG - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 3,279,401 shares of the company's stock, valued at approximately $
Get 10x Genomics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TXG and its competitors with MarketBeat's FREE daily newsletter.

TXG Media Mentions By Week

TXG Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TXG
News Sentiment

1.10

1.03

Average
Medical
News Sentiment

TXG News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TXG Articles
This Week

20

7

TXG Articles
Average Week

Get 10x Genomics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TXG and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:TXG) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners